C-reactive protein promotes adhesion of monocytes to endothelial cells via NADPH oxidase-mediated oxidative stress

Journal of Cellular Biochemistry

Volumn 113, Issue 3, 2012, Pages 857-867

  Huang, Xiuqing ^a   Zhang, Jing ^b   Liu, Jin ^c   Sun, Liang ^a   Zhao, Hongye ^a   Lu, Yonggang ^a   Wang, Jianchang ^b   Li, Jian ^a  

^a BEIJING HOSPITAL   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

Author keywords

C Reactive Protein; Intima Media Thickness; Monocytes; Nadph Oxidase

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; CELL ADHESION; CELLS, CULTURED; CHEMOKINE CCL2; CHOLESTEROL, HDL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; MALE; MONOCYTES; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES;

EID: 84863282319     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23415     Document Type: Article

References (35)

1. Abe N, Osanai T, Fujiwara T, Kameda K, Matsunaga T, Okumura K. 2006. C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: Inhibitory effect of fluvastatin. Life Sci 78:1021-1028. (Pubitemid 43112542)
2. Baldassarre D, De Jong A, Amato M, Werba JP, Castelnuovo S, Frigerio B, Veglia F, Tremoli E, Sirtori CR. 2008. Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis. Ann Med 40:21-44. (Pubitemid 351197923)
3. Barbieri SS, Eligini S, Brambilla M, Tremoli E, Colli S. 2003. Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: Critical role of NADPH oxidase. Cardiovasc Res 60:187-197. (Pubitemid 38373491)
4. Barton M, Minotti R, Haas E. 2007. Inflammation and atherosclerosis. Circ Res 101:750-751. (Pubitemid 350287187)
5. Butcher EC. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033-1036. (Pubitemid 121001517)
6. Cathcart MK. 2004. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: Contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 24:23-28. (Pubitemid 38082407)
7. Climent I, Tsai L, Levine RL. 1989. Derivatization of gamma-glutamyl semialdehyde residues in oxidized proteins by fluoresceinamine. Anal Biochem 182:226-232. (Pubitemid 19277096)
8. Devaraj S, Singh U, Jialal I. 2009. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 55:229-238.
9. Dogramaci AC, Balci DD, Balci A, Karazincir S, Savas N, Topaloglu C, Yalcin F. 2009. Is androgenetic alopecia a risk for atherosclerosis? J Eur Acad Dermatol Venereol 23:673-677.
10. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752-1761. (Pubitemid 40385531)
11. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rosenzweig A. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718-723.
12. Hansson GK, Robertson AK, Soderberg-Naucler C. 2006. Inflammation and atherosclerosis. Annu Rev Pathol 1:297-329.
13. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 94:12053-12058. (Pubitemid 27467841)
14. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE. 1999. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 100:96-102. (Pubitemid 29297946)
15. Levine RL. 1983. Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue. J Biol Chem 258:11823-11827.
16. Libby P, Okamoto Y, Rocha VZ, Folco E. 2010. Inflammation in atherosclerosis: Transition from theory to practice. Circ J 74:213-220.
17. Nakagomi A, Sasaki M, Ishikawa Y, Morikawa M, Shibui T, Kusama Y, Atarashi H, Mizuno K. 2010. Upregulation of monocyte tissue factor activity is significantly associated with low-grade chronic inflammation and insulin resistance in patients with metabolic syndrome. Circ J 74:572-577.
18. Pasceri V, Cheng JS, Willerson JT, Yeh ET. 2001. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531-2534. (Pubitemid 32521959)
19. Pasceri V, Willerson JT, Yeh ET. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165-2168.
20. Pepys MB, Hirschfield GM. 2003. C-reactive protein: A critical update. J Clin Invest 111:1805-1812. (Pubitemid 38057722)
21. Perez-Matute P, Zulet MA, Martinez JA. 2009. Reactive species and diabetes: Counteracting oxidative stress to improve health. Curr Opin Pharmacol 9:771-779.
22. Piconi L, Corgnali M, Da Ros R, Assaloni R, Piliego T, Ceriello A. 2008. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. J Diabetes Complications 22:38-45.
23. Reape TJ, Groot PH. 1999. Chemokines and atherosclerosis. Atherosclerosis 147:213-225. (Pubitemid 29512252)
24. Rivett AJ. 1986. Regulation of intracellular protein turnover: Covalent modification as a mechanism of marking proteins for degradation. Curr Top Cell Regul 28:291-337.
25. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. 2002. Aldosteroneinduced inflammation in the rat heart: Role of oxidative stress. Am J Pathol 161:1773-1781. (Pubitemid 35265535)
26. Takahashi M, Suzuki E, Takeda R, Oba S, Nishimatsu H, Kimura K, Nagano T, Nagai R, Hirata Y. 2008. Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: Roles of NF-kappaB, p38, and reactive oxygen species. Am J Physiol Heart Circ Physiol 294:H2879-H2888.
27. Takeya R, Ueno N, Sumimoto H. 2006. Regulation of superoxide-producing NADPH oxidases in nonphagocytic cells. Methods Enzymol 406:456-468. (Pubitemid 43207459)
28. Takiuchi S, Kamide K, Miwa Y, Tomiyama M, Yoshii M, Matayoshi T, Horio T, Kawano Y. 2004. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens 18:17-23. (Pubitemid 38165517)
29. Verma S, Devaraj S, Jialal I. 2006. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 113:2135-2150; discussion 2150.
30. Wolff SP, Dean RT. 1986. Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis. Biochem J 234:399-403. (Pubitemid 16049840)
31. Yamamori T, Inanami O, Nagahata H, Cui Y, Kuwabara M. 2000. Roles of p38 MAPK, PKC and PI3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes. FEBS Lett 467:253-258. (Pubitemid 30081745)
32. Yasunari K, Maeda K, Nakamura M, Yoshikawa J. 2002. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 39:777-780. (Pubitemid 34252874)
33. Yuan H, Lu Y, Huang X, He Q, Man Y, Zhou Y, Wang S, Li J. 2010. Suppression of NADPH oxidase 2 substantially restores glucose-induced dysfunction of pancreatic NIT-1cells. FEBS J 277:5061-5071.
34. Zhao X, Bey EA, Wientjes FB, Cathcart MK. 2002. Cytosolic phospholipase A2 (cPLA2) regulation of human monocyte NADPH oxidase activity. cPLA2 affects translocation but not phosphorylation of p67(phox) and p47(phox). J Biol Chem 277:25385-25392. (Pubitemid 34951850)
35. Zhao X, Carnevale KA, Cathcart MK. 2003. Human monocytes use Rac1, not Rac2, in the NADPH oxidase complex. J Biol Chem 278:40788-40792. (Pubitemid 37280896)